Blood Test Predicts Which Patients with Lung Cancer Will Benefit from Newly Approved Immunotherapy Drug
January 14, 2026
January 14, 2026
BOSTON, Massachusetts, Jan. 14 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Blood Test Predicts Which Patients with Lung Cancer Will Benefit from Newly Approved Immunotherapy Drug
*
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lastin . . .
* * *
Blood Test Predicts Which Patients with Lung Cancer Will Benefit from Newly Approved Immunotherapy Drug
*
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lastin . . .